Semaglutide is a peptide that must be injected once a week. The dose starts low and increases over 16 weeks to reach the maximum dose for weight loss. The food you eat will remain in the stomach a little longer making you feel full sooner and limiting overeating. Insulin secretion will be optimized to carry sugar to the cell and not store fat. Semaglutide also mimics a hormone that targets areas of the brain to reduce appetite.

Candidates for Semaglutide have a BMI over 30, or over 27 with at least one related condition such as high blood pressure, high cholesterol or diabetes (Type 2). Or patients can have a body fat % of 30+ for females or 25+ for males. Clients who have tried other forms of weight loss or appetite suppressants may be great candidates for Semaglutide.